BioNexus Gene Lab Corp (BGLC)
NASDAQ:BGLC
US Market
Holding BGLC?
Track your performance easily

BioNexus Gene Lab Corp (BGLC) Financial Statements

53 Followers

BioNexus Gene Lab Corp Financial Overview

BioNexus Gene Lab Corp's market cap is currently ―. The company's EPS TTM is $-0.132; its P/E ratio is -2.41; BioNexus Gene Lab Corp is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 1.97M$ 2.38M$ 2.55M$ 2.57M$ 2.38M
Gross Profit$ 288.72K$ 365.03K$ 354.33K$ 339.71K$ 368.90K
EBIT$ 259.17K$ -74.37K$ -2.53M$ -272.20K$ -48.19K
EBITDA$ 290.63K$ -44.78K$ -2.50M$ -247.59K$ -23.32K
Net Income Common Stockholders$ 199.10K$ -103.76K$ -2.61M$ -259.25K$ -69.07K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.20M$ 2.49M$ 4.70M$ 297.08K$ 406.79K
Total Assets$ 11.14M$ 11.16M$ 11.47M$ 7.90M$ 8.19M
Total Debt$ 235.91K$ 121.35K$ 138.76K$ 45.76K$ 52.41K
Net Debt$ -1.96M$ -2.37M$ -4.57M$ -251.33K$ -354.38K
Total Liabilities$ 1.59M$ 1.82M$ 1.78M$ 1.94M$ 1.63M
Stockholders Equity$ 9.55M$ 9.34M$ 9.69M$ 5.96M$ 6.56M
Cash Flow-
Free Cash Flow$ -720.72K$ -208.69K$ -1.03M$ 17.97K$ -130.16K
Operating Cash Flow$ -670.54K$ -34.44K$ -899.35K$ -23.82K$ -116.52K
Investing Cash Flow$ 83.06K$ 24.10K$ -360.71K$ -3.06K$ -5.06K
Financing Cash Flow$ 173.58K$ 24.22K$ 5.75M$ -2.43K$ -1.78K
Currency in USD

BioNexus Gene Lab Corp Earnings and Revenue History

BioNexus Gene Lab Corp Debt to Assets

BioNexus Gene Lab Corp Cash Flow

BioNexus Gene Lab Corp Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis